Figure 5From: Cellular and humoral immune responses against the Plasmodium vivax MSP-119 malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of BrazilAnalysis of cellular proliferation after 96 hour culture by cytometry flow using a CFSE vital staining. PBMC from malaria patients and control individuals in the absence or presence of plasmodial antigens (PvMSP-119 and PSS1 crude antigen) or PHA mitogen. *p = 0.02 malaria versus control individualsBack to article page